View in EDS

Overcoming Acquired Epigenetic Resistance to BTK Inhibitors.

Saved in:
Bibliographic Details
Title: Overcoming Acquired Epigenetic Resistance to BTK Inhibitors.
Authors: Shaffer AL 3rd; Lymphoid Malignancies Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland. lstaudt@mail.nih.gov arthurlshaffer3@gmail.com., Phelan JD; Lymphoid Malignancies Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland., Wang JQ; Lymphoid Malignancies Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland., Huang D; Lymphoid Malignancies Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland., Wright GW; Biometric Research Program, Division of Cancer Diagnosis and Treatment, National Cancer Institute, National Institutes of Health, Bethesda, Maryland., Kasbekar M; Lymphoid Malignancies Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland., Choi J; Lymphoid Malignancies Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland., Young RM; Lymphoid Malignancies Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland., Webster DE; Lymphoid Malignancies Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland., Yang Y; Lymphoid Malignancies Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland., Zhao H; Lymphoid Malignancies Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland., Yu X; Lymphoid Malignancies Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland., Xu W; Lymphoid Malignancies Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland., Roulland S; Lymphoid Malignancies Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland., Ceribelli M; Lymphoid Malignancies Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland.; Division of Preclinical Innovation, National Center for Advancing Translational Sciences, National Institutes of Health, Bethesda, Maryland., Zhang X; Division of Preclinical Innovation, National Center for Advancing Translational Sciences, National Institutes of Health, Bethesda, Maryland., Wilson KM; Division of Preclinical Innovation, National Center for Advancing Translational Sciences, National Institutes of Health, Bethesda, Maryland., Chen L; Division of Preclinical Innovation, National Center for Advancing Translational Sciences, National Institutes of Health, Bethesda, Maryland., McKnight C; Division of Preclinical Innovation, National Center for Advancing Translational Sciences, National Institutes of Health, Bethesda, Maryland., Klumpp-Thomas C; Division of Preclinical Innovation, National Center for Advancing Translational Sciences, National Institutes of Health, Bethesda, Maryland., Thomas CJ; Lymphoid Malignancies Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland.; Division of Preclinical Innovation, National Center for Advancing Translational Sciences, National Institutes of Health, Bethesda, Maryland., Häupl B; Department of Medicine II, Hematology/Oncology, Goethe University, Frankfurt; German Cancer Consortium/German Cancer Research Center, Heidelberg; and Department of Molecular Diagnostics and Translational Proteomics, Frankfurt Cancer Institute, Frankfurt, Germany., Oellerich T; Department of Medicine II, Hematology/Oncology, Goethe University, Frankfurt; German Cancer Consortium/German Cancer Research Center, Heidelberg; and Department of Molecular Diagnostics and Translational Proteomics, Frankfurt Cancer Institute, Frankfurt, Germany., Rae Z; Cancer Research Technology Program, Single-Cell Analysis Facility, Frederick National Laboratory for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland., Kelly MC; Cancer Research Technology Program, Single-Cell Analysis Facility, Frederick National Laboratory for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland., Ahn IE; Hematology Branch, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, Maryland., Sun C; Hematology Branch, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, Maryland., Gaglione EM; Hematology Branch, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, Maryland., Wilson WH; Lymphoid Malignancies Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland., Wiestner A; Hematology Branch, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, Maryland., Staudt LM; Lymphoid Malignancies Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland. lstaudt@mail.nih.gov arthurlshaffer3@gmail.com.
Source: Blood cancer discovery [Blood Cancer Discov] 2021 Sep 14; Vol. 2 (6), pp. 630-647. Date of Electronic Publication: 2021 Sep 14 (Print Publication: 2021).
Publication Type: Journal Article; Research Support, N.I.H., Intramural
Journal Info: Publisher: American Association for Cancer Research Country of Publication: United States NLM ID: 101764786 Publication Model: eCollection Cited Medium: Internet ISSN: 2643-3249 (Electronic) Linking ISSN: 26433230 NLM ISO Abbreviation: Blood Cancer Discov
Database: MEDLINE Ultimate
FullText Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 34778802
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Overcoming Acquired Epigenetic Resistance to BTK Inhibitors.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Shaffer+AL+3rd%22">Shaffer AL 3rd</searchLink>; Lymphoid Malignancies Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland. lstaudt@mail.nih.gov arthurlshaffer3@gmail.com.<br /><searchLink fieldCode="AU" term="%22Phelan+JD%22">Phelan JD</searchLink>; Lymphoid Malignancies Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland.<br /><searchLink fieldCode="AU" term="%22Wang+JQ%22">Wang JQ</searchLink>; Lymphoid Malignancies Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland.<br /><searchLink fieldCode="AU" term="%22Huang+D%22">Huang D</searchLink>; Lymphoid Malignancies Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland.<br /><searchLink fieldCode="AU" term="%22Wright+GW%22">Wright GW</searchLink>; Biometric Research Program, Division of Cancer Diagnosis and Treatment, National Cancer Institute, National Institutes of Health, Bethesda, Maryland.<br /><searchLink fieldCode="AU" term="%22Kasbekar+M%22">Kasbekar M</searchLink>; Lymphoid Malignancies Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland.<br /><searchLink fieldCode="AU" term="%22Choi+J%22">Choi J</searchLink>; Lymphoid Malignancies Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland.<br /><searchLink fieldCode="AU" term="%22Young+RM%22">Young RM</searchLink>; Lymphoid Malignancies Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland.<br /><searchLink fieldCode="AU" term="%22Webster+DE%22">Webster DE</searchLink>; Lymphoid Malignancies Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland.<br /><searchLink fieldCode="AU" term="%22Yang+Y%22">Yang Y</searchLink>; Lymphoid Malignancies Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland.<br /><searchLink fieldCode="AU" term="%22Zhao+H%22">Zhao H</searchLink>; Lymphoid Malignancies Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland.<br /><searchLink fieldCode="AU" term="%22Yu+X%22">Yu X</searchLink>; Lymphoid Malignancies Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland.<br /><searchLink fieldCode="AU" term="%22Xu+W%22">Xu W</searchLink>; Lymphoid Malignancies Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland.<br /><searchLink fieldCode="AU" term="%22Roulland+S%22">Roulland S</searchLink>; Lymphoid Malignancies Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland.<br /><searchLink fieldCode="AU" term="%22Ceribelli+M%22">Ceribelli M</searchLink>; Lymphoid Malignancies Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland.; Division of Preclinical Innovation, National Center for Advancing Translational Sciences, National Institutes of Health, Bethesda, Maryland.<br /><searchLink fieldCode="AU" term="%22Zhang+X%22">Zhang X</searchLink>; Division of Preclinical Innovation, National Center for Advancing Translational Sciences, National Institutes of Health, Bethesda, Maryland.<br /><searchLink fieldCode="AU" term="%22Wilson+KM%22">Wilson KM</searchLink>; Division of Preclinical Innovation, National Center for Advancing Translational Sciences, National Institutes of Health, Bethesda, Maryland.<br /><searchLink fieldCode="AU" term="%22Chen+L%22">Chen L</searchLink>; Division of Preclinical Innovation, National Center for Advancing Translational Sciences, National Institutes of Health, Bethesda, Maryland.<br /><searchLink fieldCode="AU" term="%22McKnight+C%22">McKnight C</searchLink>; Division of Preclinical Innovation, National Center for Advancing Translational Sciences, National Institutes of Health, Bethesda, Maryland.<br /><searchLink fieldCode="AU" term="%22Klumpp-Thomas+C%22">Klumpp-Thomas C</searchLink>; Division of Preclinical Innovation, National Center for Advancing Translational Sciences, National Institutes of Health, Bethesda, Maryland.<br /><searchLink fieldCode="AU" term="%22Thomas+CJ%22">Thomas CJ</searchLink>; Lymphoid Malignancies Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland.; Division of Preclinical Innovation, National Center for Advancing Translational Sciences, National Institutes of Health, Bethesda, Maryland.<br /><searchLink fieldCode="AU" term="%22Häupl+B%22">Häupl B</searchLink>; Department of Medicine II, Hematology/Oncology, Goethe University, Frankfurt; German Cancer Consortium/German Cancer Research Center, Heidelberg; and Department of Molecular Diagnostics and Translational Proteomics, Frankfurt Cancer Institute, Frankfurt, Germany.<br /><searchLink fieldCode="AU" term="%22Oellerich+T%22">Oellerich T</searchLink>; Department of Medicine II, Hematology/Oncology, Goethe University, Frankfurt; German Cancer Consortium/German Cancer Research Center, Heidelberg; and Department of Molecular Diagnostics and Translational Proteomics, Frankfurt Cancer Institute, Frankfurt, Germany.<br /><searchLink fieldCode="AU" term="%22Rae+Z%22">Rae Z</searchLink>; Cancer Research Technology Program, Single-Cell Analysis Facility, Frederick National Laboratory for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland.<br /><searchLink fieldCode="AU" term="%22Kelly+MC%22">Kelly MC</searchLink>; Cancer Research Technology Program, Single-Cell Analysis Facility, Frederick National Laboratory for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland.<br /><searchLink fieldCode="AU" term="%22Ahn+IE%22">Ahn IE</searchLink>; Hematology Branch, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, Maryland.<br /><searchLink fieldCode="AU" term="%22Sun+C%22">Sun C</searchLink>; Hematology Branch, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, Maryland.<br /><searchLink fieldCode="AU" term="%22Gaglione+EM%22">Gaglione EM</searchLink>; Hematology Branch, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, Maryland.<br /><searchLink fieldCode="AU" term="%22Wilson+WH%22">Wilson WH</searchLink>; Lymphoid Malignancies Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland.<br /><searchLink fieldCode="AU" term="%22Wiestner+A%22">Wiestner A</searchLink>; Hematology Branch, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, Maryland.<br /><searchLink fieldCode="AU" term="%22Staudt+LM%22">Staudt LM</searchLink>; Lymphoid Malignancies Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland. lstaudt@mail.nih.gov arthurlshaffer3@gmail.com.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101764786%22">Blood cancer discovery</searchLink> [Blood Cancer Discov] 2021 Sep 14; Vol. 2 (6), pp. 630-647. <i>Date of Electronic Publication: </i>2021 Sep 14 (<i>Print Publication: </i>2021).
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article; Research Support, N.I.H., Intramural
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22American+Association+for+Cancer+Research%22">American Association for Cancer Research </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>101764786 <i>Publication Model: </i>eCollection <i>Cited Medium: </i>Internet <i>ISSN: </i>2643-3249 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2226433230%22">26433230 </searchLink><i>NLM ISO Abbreviation: </i>Blood Cancer Discov
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=34778802
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1158/2643-3230.BCD-21-0063
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 630
    Titles:
      – TitleFull: Overcoming Acquired Epigenetic Resistance to BTK Inhibitors.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Shaffer AL 3rd
      – PersonEntity:
          Name:
            NameFull: Phelan JD
      – PersonEntity:
          Name:
            NameFull: Wang JQ
      – PersonEntity:
          Name:
            NameFull: Huang D
      – PersonEntity:
          Name:
            NameFull: Wright GW
      – PersonEntity:
          Name:
            NameFull: Kasbekar M
      – PersonEntity:
          Name:
            NameFull: Choi J
      – PersonEntity:
          Name:
            NameFull: Young RM
      – PersonEntity:
          Name:
            NameFull: Webster DE
      – PersonEntity:
          Name:
            NameFull: Yang Y
      – PersonEntity:
          Name:
            NameFull: Zhao H
      – PersonEntity:
          Name:
            NameFull: Yu X
      – PersonEntity:
          Name:
            NameFull: Xu W
      – PersonEntity:
          Name:
            NameFull: Roulland S
      – PersonEntity:
          Name:
            NameFull: Ceribelli M
      – PersonEntity:
          Name:
            NameFull: Zhang X
      – PersonEntity:
          Name:
            NameFull: Wilson KM
      – PersonEntity:
          Name:
            NameFull: Chen L
      – PersonEntity:
          Name:
            NameFull: McKnight C
      – PersonEntity:
          Name:
            NameFull: Klumpp-Thomas C
      – PersonEntity:
          Name:
            NameFull: Thomas CJ
      – PersonEntity:
          Name:
            NameFull: Häupl B
      – PersonEntity:
          Name:
            NameFull: Oellerich T
      – PersonEntity:
          Name:
            NameFull: Rae Z
      – PersonEntity:
          Name:
            NameFull: Kelly MC
      – PersonEntity:
          Name:
            NameFull: Ahn IE
      – PersonEntity:
          Name:
            NameFull: Sun C
      – PersonEntity:
          Name:
            NameFull: Gaglione EM
      – PersonEntity:
          Name:
            NameFull: Wilson WH
      – PersonEntity:
          Name:
            NameFull: Wiestner A
      – PersonEntity:
          Name:
            NameFull: Staudt LM
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 14
              M: 09
              Text: 2021 Sep 14
              Type: published
              Y: 2021
          Identifiers:
            – Type: issn-electronic
              Value: 2643-3249
          Numbering:
            – Type: volume
              Value: 2
            – Type: issue
              Value: 6
          Titles:
            – TitleFull: Blood cancer discovery
              Type: main
ResultId 1